Selected research
Market Analysis & Forecast
Global Veterinary Anti-Infectives Market Analysis and Forecast 2026-2032
Market perspective
The global Veterinary Anti-Infectives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Veterinary Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Veterinary Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Veterinary Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Veterinary Anti-Infectives is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Veterinary Anti-Infectives include Zoetis Animal Healthcare, Merck, Bayer Healthcare, Virbac, Merial (Sanofi), Elanco, Ceva Animal Health and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Veterinary Anti-Infectives, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Veterinary Anti-Infectives, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Anti-Infectives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Anti-Infectives revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Anti-Infectives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Anti-Infectives revenue, projected growth trends, production technology, application and end-user industry.
Veterinary Anti-Infectives Segment by Company
Zoetis Animal Healthcare
Merck
Bayer Healthcare
Virbac
Merial (Sanofi)
Elanco
Ceva Animal Health
Boehringer Ingelheim
Veterinary Anti-Infectives Segment by Type
Oxytetracycline
Freeze-dried Ceftiofur
Marbofloxacin
Florfenicol
Aminosidine
Beta-lactams
Veterinary Anti-Infectives Segment by Application
Companion Animals
Farm Animals
Others
Veterinary Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Veterinary Anti-Infectives in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Veterinary Anti-Infectives company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Anti-Infectives revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oxytetracycline
- Freeze-dried Ceftiofur
- Marbofloxacin
- Florfenicol
- Aminosidine
- Beta-lactams
Applications
- Companion Animals
- Farm Animals
- Others
Companies covered
- Zoetis Animal Healthcare
- Merck
- Bayer Healthcare
- Virbac
- Merial (Sanofi)
- Elanco
- Ceva Animal Health
- Boehringer Ingelheim
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Veterinary Anti-Infectives Market by Type
- 1.2.1 Global Veterinary Anti-Infectives Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Oxytetracycline
- 1.2.3 Freeze-dried Ceftiofur
- 1.2.4 Marbofloxacin
- 1.2.5 Florfenicol
- 1.2.6 Aminosidine
- 1.2.7 Beta-lactams
- 1.3 Veterinary Anti-Infectives Market by Application
- 1.3.1 Global Veterinary Anti-Infectives Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Companion Animals
- 1.3.3 Farm Animals
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Anti-Infectives Market Dynamics
- 2.1 Veterinary Anti-Infectives Industry Trends
- 2.2 Veterinary Anti-Infectives Industry Drivers
- 2.3 Veterinary Anti-Infectives Industry Opportunities and Challenges
- 2.4 Veterinary Anti-Infectives Industry Restraints
3 Global Growth Perspective
- 3.1 Global Veterinary Anti-Infectives Market Perspective (2021-2032)
- 3.2 Global Veterinary Anti-Infectives Growth Trends by Region
- 3.2.1 Global Veterinary Anti-Infectives Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Veterinary Anti-Infectives Market Size by Region (2021-2026)
- 3.2.3 Global Veterinary Anti-Infectives Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Veterinary Anti-Infectives Revenue by Players
- 4.1.1 Global Veterinary Anti-Infectives Revenue by Players (2021-2026)
- 4.1.2 Global Veterinary Anti-Infectives Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Veterinary Anti-Infectives Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Veterinary Anti-Infectives Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Veterinary Anti-Infectives Key Players Headquarters & Area Served
- 4.4 Global Veterinary Anti-Infectives Players, Product Type & Application
- 4.5 Global Veterinary Anti-Infectives Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Veterinary Anti-Infectives Market CR5 and HHI
- 4.6.3 2025 Veterinary Anti-Infectives Tier 1, Tier 2, and Tier 3
5 Veterinary Anti-Infectives Market Size by Type
- 5.1 Global Veterinary Anti-Infectives Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 5.3 Global Veterinary Anti-Infectives Revenue Market Share by Type (2021-2032)
6 Veterinary Anti-Infectives Market Size by Application
- 6.1 Global Veterinary Anti-Infectives Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 6.3 Global Veterinary Anti-Infectives Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Zoetis Animal Healthcare
- 7.1.1 Zoetis Animal Healthcare Company Information
- 7.1.2 Zoetis Animal Healthcare Business Overview
- 7.1.3 Zoetis Animal Healthcare Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.1.4 Zoetis Animal Healthcare Veterinary Anti-Infectives Product Portfolio
- 7.1.5 Zoetis Animal Healthcare Recent Developments
- 7.2 Merck
- 7.2.1 Merck Company Information
- 7.2.2 Merck Business Overview
- 7.2.3 Merck Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.2.4 Merck Veterinary Anti-Infectives Product Portfolio
- 7.2.5 Merck Recent Developments
- 7.3 Bayer Healthcare
- 7.3.1 Bayer Healthcare Company Information
- 7.3.2 Bayer Healthcare Business Overview
- 7.3.3 Bayer Healthcare Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.3.4 Bayer Healthcare Veterinary Anti-Infectives Product Portfolio
- 7.3.5 Bayer Healthcare Recent Developments
- 7.4 Virbac
- 7.4.1 Virbac Company Information
- 7.4.2 Virbac Business Overview
- 7.4.3 Virbac Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.4.4 Virbac Veterinary Anti-Infectives Product Portfolio
- 7.4.5 Virbac Recent Developments
- 7.5 Merial (Sanofi)
- 7.5.1 Merial (Sanofi) Company Information
- 7.5.2 Merial (Sanofi) Business Overview
- 7.5.3 Merial (Sanofi) Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.5.4 Merial (Sanofi) Veterinary Anti-Infectives Product Portfolio
- 7.5.5 Merial (Sanofi) Recent Developments
- 7.6 Elanco
- 7.6.1 Elanco Company Information
- 7.6.2 Elanco Business Overview
- 7.6.3 Elanco Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.6.4 Elanco Veterinary Anti-Infectives Product Portfolio
- 7.6.5 Elanco Recent Developments
- 7.7 Ceva Animal Health
- 7.7.1 Ceva Animal Health Company Information
- 7.7.2 Ceva Animal Health Business Overview
- 7.7.3 Ceva Animal Health Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.7.4 Ceva Animal Health Veterinary Anti-Infectives Product Portfolio
- 7.7.5 Ceva Animal Health Recent Developments
- 7.8 Boehringer Ingelheim
- 7.8.1 Boehringer Ingelheim Company Information
- 7.8.2 Boehringer Ingelheim Business Overview
- 7.8.3 Boehringer Ingelheim Veterinary Anti-Infectives Revenue and Gross Margin (2021-2026)
- 7.8.4 Boehringer Ingelheim Veterinary Anti-Infectives Product Portfolio
- 7.8.5 Boehringer Ingelheim Recent Developments
8 North America
- 8.1 North America Veterinary Anti-Infectives Revenue (2021-2032)
- 8.2 North America Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 8.2.1 North America Veterinary Anti-Infectives Revenue by Type (2021-2026)
- 8.2.2 North America Veterinary Anti-Infectives Revenue by Type (2027-2032)
- 8.3 North America Veterinary Anti-Infectives Revenue Share by Type (2021-2032)
- 8.4 North America Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 8.4.1 North America Veterinary Anti-Infectives Revenue by Application (2021-2026)
- 8.4.2 North America Veterinary Anti-Infectives Revenue by Application (2027-2032)
- 8.5 North America Veterinary Anti-Infectives Revenue Share by Application (2021-2032)
- 8.6 North America Veterinary Anti-Infectives Revenue by Country
- 8.6.1 North America Veterinary Anti-Infectives Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Veterinary Anti-Infectives Revenue by Country (2021-2026)
- 8.6.3 North America Veterinary Anti-Infectives Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Veterinary Anti-Infectives Revenue (2021-2032)
- 9.2 Europe Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 9.2.1 Europe Veterinary Anti-Infectives Revenue by Type (2021-2026)
- 9.2.2 Europe Veterinary Anti-Infectives Revenue by Type (2027-2032)
- 9.3 Europe Veterinary Anti-Infectives Revenue Share by Type (2021-2032)
- 9.4 Europe Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 9.4.1 Europe Veterinary Anti-Infectives Revenue by Application (2021-2026)
- 9.4.2 Europe Veterinary Anti-Infectives Revenue by Application (2027-2032)
- 9.5 Europe Veterinary Anti-Infectives Revenue Share by Application (2021-2032)
- 9.6 Europe Veterinary Anti-Infectives Revenue by Country
- 9.6.1 Europe Veterinary Anti-Infectives Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Veterinary Anti-Infectives Revenue by Country (2021-2026)
- 9.6.3 Europe Veterinary Anti-Infectives Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Veterinary Anti-Infectives Revenue (2021-2032)
- 10.2 China Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 10.2.1 China Veterinary Anti-Infectives Revenue by Type (2021-2026)
- 10.2.2 China Veterinary Anti-Infectives Revenue by Type (2027-2032)
- 10.3 China Veterinary Anti-Infectives Revenue Share by Type (2021-2032)
- 10.4 China Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 10.4.1 China Veterinary Anti-Infectives Revenue by Application (2021-2026)
- 10.4.2 China Veterinary Anti-Infectives Revenue by Application (2027-2032)
- 10.5 China Veterinary Anti-Infectives Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Veterinary Anti-Infectives Revenue (2021-2032)
- 11.2 Asia Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 11.2.1 Asia Veterinary Anti-Infectives Revenue by Type (2021-2026)
- 11.2.2 Asia Veterinary Anti-Infectives Revenue by Type (2027-2032)
- 11.3 Asia Veterinary Anti-Infectives Revenue Share by Type (2021-2032)
- 11.4 Asia Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 11.4.1 Asia Veterinary Anti-Infectives Revenue by Application (2021-2026)
- 11.4.2 Asia Veterinary Anti-Infectives Revenue by Application (2027-2032)
- 11.5 Asia Veterinary Anti-Infectives Revenue Share by Application (2021-2032)
- 11.6 Asia Veterinary Anti-Infectives Revenue by Country
- 11.6.1 Asia Veterinary Anti-Infectives Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Veterinary Anti-Infectives Revenue by Country (2021-2026)
- 11.6.3 Asia Veterinary Anti-Infectives Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Veterinary Anti-Infectives Revenue (2021-2032)
- 12.2 SAMEA Veterinary Anti-Infectives Revenue by Type (2021-2032)
- 12.2.1 SAMEA Veterinary Anti-Infectives Revenue by Type (2021-2026)
- 12.2.2 SAMEA Veterinary Anti-Infectives Revenue by Type (2027-2032)
- 12.3 SAMEA Veterinary Anti-Infectives Revenue Share by Type (2021-2032)
- 12.4 SAMEA Veterinary Anti-Infectives Revenue by Application (2021-2032)
- 12.4.1 SAMEA Veterinary Anti-Infectives Revenue by Application (2021-2026)
- 12.4.2 SAMEA Veterinary Anti-Infectives Revenue by Application (2027-2032)
- 12.5 SAMEA Veterinary Anti-Infectives Revenue Share by Application (2021-2032)
- 12.6 SAMEA Veterinary Anti-Infectives Revenue by Country
- 12.6.1 SAMEA Veterinary Anti-Infectives Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Veterinary Anti-Infectives Revenue by Country (2021-2026)
- 12.6.3 SAMEA Veterinary Anti-Infectives Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst